🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Opioid-Related Disorders

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo NavSTAR Implementation Effectiveness Trial Across a Health System NCT07262190NA1 site📍 Philadelphia Friends Research Institute, Inc. · Tests: NavSTAR (Philly adaptation) TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) NCT07171359NA1 site📍 Portland Washington State University · Tests: TMS Low-Dose, TMS High-Dose Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic NCT07176351Phase 41 site📍 New Haven Yale University · Tests: Buprenorphine Ketamine Assisted Psychotherapy for Opioid Use Disorder NCT04892251Phase 1, Phase 21 site📍 Salt Lake City University of Utah · Tests: MORE+KAP, MORE Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons NCT06999811NA1 site📍 Charleston Medical University of South Carolina · Tests: Empowering Pregnant Women and People Receiving medications for opioid use disorder (EMPWR), Medication monitoring (cont… Resilience Among Individuals With Opioid Use Disorder NCT06954402NA2 sites📍 Baltimore📍 Baltimore Johns Hopkins University · Tests: Acute Stress Intervention (MAST-based), Non-Stress Intervention (NST-based) Evaluating Buspirone to Treat Opioid Withdrawal NCT05511909Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Buspirone, Lofexidine, Placebo Opioid/Benzodiazepine Polydrug Abuse: Aim 3 NCT05006079Phase 21 site📍 Detroit Wayne State University · Tests: Morphine, Alprazolam, Placebo Social Network Overdose Prevention and Education Intervention NCT06327061NA1 site📍 Baltimore Johns Hopkins Bloomberg School of Public Health · Tests: Network overdose prevention, Standard of care health education Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder NCT06067737Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Psilocybin, Psilocybin Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine NCT07278518NA1 site📍 Charleston Medical University of South Carolina · Tests: Patient Decision Aid for Opioid Use Disorder Reducing Opioid Use for Chronic Pain Patients Following Surgery NCT03675386NA1 site📍 Toronto University Health Network, Toronto · Tests: Interventional Group, Control Intervention The Road to Recovery Initiative (R2RI) NCT06639373n/a1 site📍 Vancouver BC Centre on Substance Use · Tests: Specialized clinical service access Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites📍 Los Angeles📍 Washington D.C.📍 Baton Rouge Montefiore Medical Center · Tests: Standard of Care Referral, Low Threshold Buprenorphine Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data NCT06768814NA1 site📍 Seattle University of Washington · Tests: Sub-acute stabilization Emergency Medicine Peer Outreach Worker Engagement for Recovery NCT06320015n/a1 site📍 Providence University of California, Los Angeles · Tests: Substance Misuse Assistance Response Team (SMART), Usual Care Group Disclosure Intervention for People in Treatment for Opioid Use Disorder NCT06458985NA1 site📍 Wilmington University of Delaware · Tests: Disclosing Recovery: A Decision Aid and Toolkit Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder NCT06521476Phase 21 site📍 Pittsburgh Sanjay R Patel · Tests: Acetazolamide, Placebo OMAR Opioid Use Disorder NCT05683184Phase 11 site📍 New Haven Yale University · Tests: [11C]OMAR Kentucky Women's Justice Community Overdose Innovation Network - Phase II NCT07179614NA3 sites📍 Barbourville📍 Harlan📍 Hyden Michele Staton · Tests: Overdose Prevention Intervention Package (OPIP) Cannabidiol in Opioid Use Disorder and Chronic Pain With Buprenorphine NCT07886606EARLY Phase 11 site📍 West Haven Yale University · Tests: 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol, Beta carotene oral solution without CBD Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment NCT07342504NA1 site📍 Notre Dame University of Notre Dame · Tests: Brief opioid-informed alcohol treatment Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes NCT03923374n/a1 site📍 Pittsburgh Senthil Sadhasivam · Tests: Subutex / Buprenorphine, Fetal & Neonatal MRI, DNA/Genetic/Pharmacokenetic Blood Draws Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, Mindfulness-based Intervention to Manage Pain and Anxiety Before and After Fracture Surgery NCT07486505NA1 site📍 Hamilton McMaster University · Tests: Mindfulness Based Intervention, Educational Recording Vanderbilt Integrated Community TMS for Opioid Recovery NCT07457489NA2 sites📍 Brentwood📍 Nashville Vanderbilt University Medical Center · Tests: Device: Repetitive Transcranial Magnetic Stimulation (rTMS), Device: Repetitive Transcranial Magnetic Stimulation (rTMS) Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal NCT04939623Phase 21 site📍 Calgary University of Calgary · Tests: Probenecid Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy NCT05942313n/a1 site📍 Pittsburgh Ilana Hull · Tests: Buprenorphine/ Methadone exposure Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use NCT07218549Phase 11 site📍 Houston Christopher D. Verrico · Tests: Placebo, Oxycodone HCl, Kratom 8g, Kratom 12g, Kratom 16g Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery NCT07115030NA3 sites📍 Bridgeport📍 Enfield📍 West Haven Yale University · Tests: PCT+2HOPE
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy